Medical research
Results from study of tusamitamab ravtansine vs. docetaxel in previously treated advanced non-squamous NSCLC
A Phase III study comparing tusamitamab ravtansine with docetaxel in patients with advanced non-squamous non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy and immunotherapy (in combination ...
Sep 10, 2024
0
0
